Back to Agenda
Session 11: Bitesize Topics & Open Community Forum
Session Chair(s)
Francine Lane, MBA
Senior Director of Product Management, Citeline, United States
Merete Joergensen, MBA, MSC
Clinical Disclosure and Transparency Expert, Merete-J Consulting, Denmark
Your Voice, Your Topics! We're thrilled to bring you a session featuring topics proposed by the DIA Disclosure Community. We've listened to your suggestions, and this session is designed to address your most pressing concerns and interests in the field of disclosure and transparency. Join us for an engaging and interactive discussion shaped by your input!
Speaker(s)
Boris Grimm
Chapter Head and Capability Owner of Clinical Trial Transparency and Data Sharin, Boehringer Ingelheim, Germany
Update on Privacy Methodology
Jeppe G. Manuel, MLIS
Data Science External Affairs & Intelligence Director, Novo Nordisk A/S, Denmark
Update on Privacy Methodology
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
Complex Clinical Trials
Sameer Sharma, MPHARM
Associate Director, Clinical Trial Transparency, Merck KGaA, Germany
CTIS and its impact on Investigator sponsored trials (ISS) or investigator-initiated trials (IIS)
Scott Feiner
Senior Manager, Trial Disclosure, AbbVie, United States
IP Dosing and Transparency issues
Have an account?